Your browser doesn't support javascript.
loading
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
Mahévas, Matthieu; Moulis, Guillaume; Andres, Emmanuel; Riviere, Etienne; Garzaro, Margaux; Crickx, Etienne; Guillotin, Vivien; Malphettes, Marion; Galicier, Lionel; Noel, Nicolas; Darnige, Luc; Terriou, Louis; Guerveno, Claire; Sanchis-Borja, Mateo; Moulinet, Thomas; Meunier, Benoit; Ebbo, Mikael; Michel, Marc; Godeau, Bertrand.
  • Mahévas M; Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
  • Moulis G; Department of Internal Medicine, Toulouse University Hospital (CHU de Toulouse), Toulouse, France.
  • Andres E; CIC 1436, Toulouse University Hospital (CHU de Toulouse), Toulouse, France.
  • Riviere E; UMR 1027 Inserm, University of Toulouse, Toulouse, France.
  • Garzaro M; Department of Internal Medicine, University Hospital of Strasbourg, Research Team EA, 3072 "Mitochondrie, Stress oxydant et Protection musculaire", University of Strasbourg, Strasbourg, France.
  • Crickx E; Department of Internal Medicine, Bordeaux University Hospital (CHU de Bordeaux), Bordeaux, France.
  • Guillotin V; Inserm U1034-University of Bordeaux, Bordeaux, France.
  • Malphettes M; Department of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Galicier L; Department of Internal Medicine, National Referral Center for Adult's Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.
  • Noel N; Department of Internal Medicine, University Hospital of Strasbourg, Research Team EA, 3072 "Mitochondrie, Stress oxydant et Protection musculaire", University of Strasbourg, Strasbourg, France.
  • Darnige L; Department of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Terriou L; Department of Clinical Immunology, Saint Louis University Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Guerveno C; Department of internal medicine, Kremlin-Bicêtre, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Sanchis-Borja M; Inserm UMR-S 1140, Service d'Hématologie Biologique, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris (AP-HP), Université de Paris, Paris, France.
  • Moulinet T; Department of Internal Medicine and Immunology, Claude-Huriez University Hospital, Université Lille Nord de France, Lille, France.
  • Meunier B; Department of Internal Medicine, Albi Hospital, Albi, France.
  • Ebbo M; Department of pneumology, Hôpital européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Michel M; Department of internal medicine, Nancy University Hospital (CHU de Nancy), University of Lorraine, Vandoeuvre-lès-Nancy, France.
  • Godeau B; Department of internal medicine, Hôpital la Timone, Assistance Publique Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.
Br J Haematol ; 190(4): e224-e229, 2020 08.
Article en En | MEDLINE | ID: mdl-32678953

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article